Daniel E. Ho's Testimony Before the California Senate Governmental Organization Committee and the Senate Budget and Fiscal Review Subcommittee No. 4 on State Administration and General Government
In this testimony presented in the California Senate Hearing “California at the Forefront: Steering AI Towards Ethical Horizons,” Daniel E. Ho offers three recommendations for how California should lead the nation in responsible AI innovation by nurturing and attracting technical talent into public service, democratizing access to computing and data resources, and addressing the information asymmetry about AI risks.
In collaboration with
Related Publications
Toward Responsible AI in Health Insurance Decision-Making
This brief proposes governance mechanisms for the growing use of AI in health insurance utilization review.
This brief proposes governance mechanisms for the growing use of AI in health insurance utilization review.
Response to OSTP's Request for Information on Accelerating the American Scientific Enterprise
Stanford scholars respond to a federal RFI on scientific discovery, calling for the government to support a new “team science” academic research model for AI-enabled discovery.
Stanford scholars respond to a federal RFI on scientific discovery, calling for the government to support a new “team science” academic research model for AI-enabled discovery.
Response to FDA's Request for Comment on AI-Enabled Medical Devices
Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.
Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.
Russ Altman’s Testimony Before the U.S. Senate Committee on Health, Education, Labor, and Pensions
In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.
In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.